Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8VHI6

Entry ID Method Resolution Chain Position Source
AF-Q8VHI6-F1 Predicted AlphaFoldDB

36 variants for Q8VHI6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388804190 37 I>M No EVA
rs3388801140 93 Q>K No EVA
rs3388799453 103 S>G No EVA
rs3388810971 135 S>I No EVA
rs3388791316 147 G>R No EVA
rs3395640322 249 S>FL* No EVA
rs3388791327 250 Y>C No EVA
rs3396110622 250 Y>F No EVA
rs3395640322 250 Y>F No EVA
rs3396110622 250 Y>FL* No EVA
rs3396339809 262 P>Q No EVA
rs214887380 263 A>V No EVA
rs3388799469 266 S>F No EVA
rs1133249722 281 G>C No EVA
rs1132468871 282 A>T No EVA
rs1133658915 287 R>* No EVA
rs1132876911 288 P>L No EVA
rs1132208183 289 S>P No EVA
rs1135143513 292 S>L No EVA
rs1133409414 311 Q>* No EVA
rs1133033592 313 P>L No EVA
rs1134458924 316 S>F No EVA
rs1134285092 319 S>F No EVA
rs1133613304 320 T>K No EVA
rs3388805057 334 I>K No EVA
rs3388817592 355 A>S No EVA
rs257173936 367 T>A No EVA
rs3388791358 375 A>T No EVA
rs3388779997 376 V>I No EVA
rs221258608 380 P>S No EVA
rs264119070 414 S>T No EVA
rs3388810401 467 E>D No EVA
rs3388801144 481 I>T No EVA
rs49378137 493 E>A No EVA
rs3396410943 501 D>A No EVA
rs3396339743 502 D>E No EVA

No associated diseases with Q8VHI6

4 regional properties for Q8VHI6

Type Name Position InterPro Accession
repeat WD40 repeat 227 - 264 IPR001680-1
repeat WD40 repeat 269 - 304 IPR001680-2
repeat WD40 repeat 349 - 390 IPR001680-3
domain BING4, C-terminal domain 441 - 519 IPR012952

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm, cytoskeleton
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
cytoskeleton A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.
glial cell projection A prolongation or process extending from a glial cell.
glutamatergic synapse A synapse that uses glutamate as a neurotransmitter.
lamellipodium A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments.
postsynapse The part of a synapse that is part of the post-synaptic cell.
SCAR complex A pentameric complex that includes orthologues of human PIR121, Nap1, Abi, SCAR, and HSPC300 and regulates actin polymerization and/or depolymerization through small GTPase mediated signal transduction.

3 GO annotations of molecular function

Name Definition
actin binding Binding to monomeric or multimeric forms of actin, including actin filaments.
Arp2/3 complex binding Binding to an Arp2/3 complex, a protein complex that contains two actin-related proteins, Arp2 and Arp3, and five novel proteins (ARPC1-5).
protein kinase A regulatory subunit binding Binding to one or both of the regulatory subunits of protein kinase A.

8 GO annotations of biological process

Name Definition
actin cytoskeleton organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.
cytoskeleton organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures.
lamellipodium assembly Formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell.
modification of postsynaptic actin cytoskeleton Any process that modifies the structure of a postsynaptic actin cytoskeleton.
oligodendrocyte development The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system.
positive regulation of Arp2/3 complex-mediated actin nucleation Any process that activates or increases the frequency, rate or extent of Arp2/3 complex-mediated actin nucleation.
positive regulation of myelination Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons.
regulation of cell shape Any process that modulates the surface configuration of a cell.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9Y6W5 WASF2 Actin-binding protein WASF2 Homo sapiens (Human) PR
Q9UPY6 WASF3 Actin-binding protein WASF3 Homo sapiens (Human) PR
10 20 30 40 50 60
MPLVKRNIEP RHLCRGALPE GVTSELECVT NSTLAAIIRQ LSSLSKHAED IFGELFNEAN
70 80 90 100 110 120
NFYIRANSLQ DRIDRLAVKV TQLDSTVEEV SLQDINMKKA FKSSTIQDQQ VVSKNSIPNP
130 140 150 160 170 180
VADIYNQSDK PPPLSILTPY RDDKKDGLKF YTDPSYFFDL WKEKMLQDTE DKRKEKRRQK
190 200 210 220 230 240
EQKRVDGTTR EVKKVRKARN RRQEWNMMAY DKELRPDNRL SQSVHHGASS EGSLSPDTRS
250 260 270 280 290 300
HTSDVTDYSY PATPNHALQA QPATPSYTAG DAPLHGTTNQ GAEHEYRPSS ASARHMALNR
310 320 330 340 350 360
PQQPPPPPPP QAPEGSQAST SVAPADYGML PAQIIEYYSP SGPPPPPPPP MIPSAQTAFV
370 380 390 400 410 420
SPLQMPTQPP FPASAVSTYP TPPHQPSTGL LATAPPPPGP PPPPPGPPGP SSLSSSPMHG
430 440 450 460 470 480
PPVAEAKRPE PAQPPISDAR SDLLAAIRMG IQLKKVQEQR EQEAKREPVG NDVATILSRR
490 500
IAVEYSDSDD DSEFDENDWS D